日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

EP17.04 SURGICAL REMOVAL OF THORACIC EPIDURAL EWING SARCOMA WITH DOUBLE DOOR LAMINOPLASTY

EP17.04 胸椎硬膜外尤文氏肉瘤双开门椎板成形术切除术

期刊:
影响因子:
doi:10.1083/jcb.5.1.143
BINGGELI, M F; Fjerza, A
发表日期：2025
文献求助 收藏

Safe and Successful Surgical Outcome in Persons with Hemophilia A with and without Inhibitors Treated with Emicizumab: A Large, Single Center, Real-World Experience

艾美赛珠单抗治疗伴或不伴抑制因子的A型血友病患者的安全成功手术结果：一项大型单中心真实世界研究

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm12062317
Castaman, Giancarlo; Linari, Silvia; Pieri, Lisa; Carulli, Christian; Prosperi, Paolo; Tonelli, Paolo; Demartis, Francesco; Fjerza, Rajmonda; Attanasio, Monica; Coppo, Mirella; Salvianti, Francesca
发表日期：2023
文献求助 收藏

Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study

JAK2(V617F)突变状态对原发性血小板增多症患者阿那格雷治疗反应的影响：一项观察性假设生成研究

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S79576
Cascavilla, Nicola; De Stefano, Valerio; Pane, Fabrizio; Pancrazzi, Alessandro; Iurlo, Alessandra; Gobbi, Marco; Palandri, Francesca; Specchia, Giorgina; Liberati, A Marina; D'Adda, Mariella; Gaidano, Gianluca; Fjerza, Rajmonda; Achenbach, Heinrich; Smith, Jonathan; Wilde, Paul; Vannucchi, Alessandro M
血小板
JAK/STAT
JAK2
发表日期：2015
文献求助 收藏

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

分子注释的原发性血小板增多症、真性红细胞增多症和骨髓纤维化的长期生存和原始细胞转化

期刊:Blood
影响因子:23.1
doi:10.1182/blood-2014-05-579136
Tefferi, Ayalew; Guglielmelli, Paola; Larson, Dirk R; Finke, Christy; Wassie, Emnet A; Pieri, Lisa; Gangat, Naseema; Fjerza, Rajmonda; Belachew, Alem A; Lasho, Terra L; Ketterling, Rhett P; Hanson, Curtis A; Rambaldi, Alessandro; Finazzi, Guido; Thiele, Juergen; Barbui, Tiziano; Pardanani, Animesh; Vannucchi, Alessandro M
血小板
细胞生物学
红细胞
发表日期：2014
文献求助 收藏

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value

骨髓增生性肿瘤中的钙网蛋白突变特异性免疫染色：发病机制见解和诊断价值

期刊:Leukemia
影响因子:12.8
doi:10.1038/leu.2014.100
A M Vannucchi, G Rotunno, N Bartalucci, G Raugei, V Carrai, M Balliu, C Mannarelli, A Pacilli, L Calabresi, R Fjerza, L Pieri, A Bosi, R Manfredini, P Guglielmelli
肿瘤
发表日期：2014
文献求助 收藏

Patients with ≥ 20 × 10(9)/l platelets at baseline may have a prompt response to romiplostim during the early phase of treatment: an italian single-institution experience

基线血小板计数≥20×10⁹/L的患者在治疗早期可能对罗米司亭有快速反应：一项意大利单中心经验

期刊:Mediterranean Journal of Hematology and Infectious Diseases
影响因子:1.5
doi:10.4084/MJHID.2012.044
Baldini, Simone; Rigacci, Luigi; Carrai, Valentina; Alterini, Renato; Fjerza, Rajmonda; Bosi, Alberto
血小板
发表日期：2012
文献求助 收藏